Startseite Blood samples for ammonia analysis do not require transport to the laboratory on ice: a study of ammonia stability and cause of in vitro ammonia increase in samples from patients with hyperammonaemia
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Blood samples for ammonia analysis do not require transport to the laboratory on ice: a study of ammonia stability and cause of in vitro ammonia increase in samples from patients with hyperammonaemia

  • Gavin W. Mercer-Smith , Marie Appleton , Élodie A. Hanon und Ann Bowron ORCID logo EMAIL logo
Veröffentlicht/Copyright: 6. Januar 2025
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Objectives

Prompt recognition of hyperammonaemia can avoid severe consequences of delayed treatment. Strict sample transport requirements present barriers to requesting and, if not achieved, rejection by the laboratory. Evidence is sparse on in vitro ammonia stability from studies using modern techniques or based in clinical settings. Stability in hyperammonaemic samples is unknown. This study aimed to examine ammonia stability and its source in samples from hyperammonaemic patients and to determine a clinically significant change to establish acceptable sample requirements for ammonia analysis.

Methods

Blood samples were taken from 19 hyperammonaemic patients and placed either on ice or kept at room temperature. Plasma ammonia was measured every 10 min for 2 h. Haemolysis index (HI), full blood count, liver enzymes and amino acids were analysed. Expert physicians were surveyed on a clinically significant ammonia change. Stability was assessed using the reference change value (RCV).

Results

Ammonia increased with time [peak value 14.9 % (8.4–17.1), median (95 % confidence interval)], and was predominately of cellular origin. Ice did not improve stability and increased HI. Survey results found a significantly increased ammonia between 39 % (30–48) at 50 μmol/L and 21 % (15–28) at 1,000 μmol/L. Ammonia RCV was 40.8 %.

Conclusions

Chilling samples did not improve blood ammonia stability. The increase in blood ammonia from patients with hyperammonaemia over 2 h was lower than that considered clinically significant and the calculated RCV. Transport of samples for ammonia analysis does not require ice and laboratories should accept samples if received within 2 h of venepuncture.


Corresponding author: Ann Bowron, Department of Blood Sciences, Newcastle upon Tyne Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle Upon Tyne, NE1 4LP, UK, E-mail:

Acknowledgments

The authors would like to thank the patients who participated in the study and the laboratory staff in the Department of Blood Sciences, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK, for their valuable help.

  1. Research ethics: Research was carried out in accordance with the Declaration of Helsinki and in accordance with the terms of the relevant local legislation. The study was reviewed and approved by the London-Bromley Research Ethics Committee (reference 22/LO/0628, 21st November 2022) and the Newcastle Joint Research Office (reference 10206).

  2. Informed consent: Informed consent was obtained from all individuals included in the study, or their legal guardians or wards.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approve its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: Not applicable.

References

1. Howanitz, JH, Howanilz, PJ, Skrodzki, CA, Iwanski, JA. Influences of specimen processing and storage conditions on results for plasma ammonia. Clin Chem 1984;30:906–8. https://doi.org/10.1093/clinchem/30.6.906.Suche in Google Scholar

2. Barsotti, RJ. Measurement of ammonia in blood. J Pediatr 2001;138:S11–20. https://doi.org/10.1067/mpd.2001.111832.Suche in Google Scholar PubMed

3. Scott, C, Olpin, S. Preanalytical and analytical aspects of ammonia determination. In: Current approach to hyperammonemia. London, UK: Future Medicine Ltd; 2015:66–77 pp.10.2217/fmeb2013.13.305Suche in Google Scholar

4. Hashim, IA, Cuthbert, JA. Elevated ammonia concentrations: potential for pre-analytical and analytical contributing factors. Clin Biochem 2014;47:233–6. https://doi.org/10.1016/j.clinbiochem.2014.08.013.Suche in Google Scholar PubMed

5. da Fonseca-Wollheim, F. Deamidation of glutamine by increased plasma gamma-glutamyltransferase is a source of rapid ammonia formation in blood and plasma specimens. Clin Chem 1990;36:1479–82.10.1093/clinchem/36.8.1479Suche in Google Scholar

6. Serice, C. Studies on the origin and significance of blood ammonia. The distribution of ammonia in whole blood, plasma and erythrocytes of man. Yale J Biol Med 1966;39.Suche in Google Scholar

7. Cojocaru, KA, Oprea, OR, Dobreanu, M. The influence of transport condition and processing time on plasma ammonia results. Acta Marisiensis – Ser Med 2022;68:24–7. https://doi.org/10.2478/amma-2022-0005.Suche in Google Scholar

8. van Anken, HC, Schiphorst, ME. A kinetic determination of ammonia in plasma. Clin Chim Acta 1974;56:151–7. https://doi.org/10.1016/0009-8981(74)90223-x.Suche in Google Scholar PubMed

9. Bowron, A, Osgood, V. Acceptability of plasma ammonia results when samples are not transported and processed under ideal conditions. Ann Clin Biochem 2024;61:230–2. https://doi.org/10.1177/00045632241232931.Suche in Google Scholar PubMed

10. Hester, J, Korzun, W, Mabry, L, Hester, JR, Korzun, WJ. Blood ammonia stability revisited. Clin Lab Sci 2015;28:173–7. https://doi.org/10.29074/ascls.28.3.173.Suche in Google Scholar

11. Aitkenhead, H. UK national audit of the measurement of ammonia. Ann Clin Biochem 2023;60:117–25. https://doi.org/10.1177/00045632231152085.Suche in Google Scholar PubMed

12. Royal College of Pathologists. Patient safety bulletin. Danger in delay [Internet]. Available from: https://www.rcpath.org/profession/patient-safety-and-quality-improvement/patient-safety-bulletins.html.Suche in Google Scholar

13. Royal College of Pathologists. Patient safety bulletin. Hyperammonaemia – it’s not always spurious [Internet]. Available from: https://www.rcpath.org/profession/patient-safety-and-quality-improvement/patient-safety-bulletins.html.Suche in Google Scholar

14. Gómez-Rioja, R, Amaro, MS, Diaz-Garzón, J, Bauçà, JM, Espartosa, DM, Fernández-Calle, P, et al.. A protocol for testing the stability of biochemical analytes. Technical document. Clin Chem Lab Med 2019;57:1829–36. https://doi.org/10.1515/cclm-2019-0586.Suche in Google Scholar PubMed

15. Fraser, C. Reference change values: the way forward in monitoring. Ann Clin Biochem 2009;46:264–5. https://doi.org/10.1258/acb.2009.009006.Suche in Google Scholar PubMed

16. Fraser, CG. Reference change values. Clin Chem Lab Med 2012;50:807–12. https://doi.org/10.1515/cclm.2011.733.Suche in Google Scholar PubMed

17. Ucar, F, Erden, G, Ozdemir, S, Ozcan, N, Bulut, E, Ozturk, A. First data on the biological variation and quality specifications for plasma ammonia concentrations in healthy subjects. Clin Chem Lab Med 2016;54:857–63. https://doi.org/10.1515/cclm-2015-0591.Suche in Google Scholar PubMed

18. Nikolac, N, Omazic, J, Simundic, AM. The evidence based practice for optimal sample quality for ammonia measurement. Clin Biochem 2014;47:991–5. https://doi.org/10.1016/j.clinbiochem.2014.05.068.Suche in Google Scholar PubMed

19. Takehana, S, Yoshida, H, Ozawa, S, Yamazaki, J, Shimbo, K, Nakayama, A, et al.. The effects of pre-analysis sample handling on human plasma amino acid concentrations. Clin Chim Acta 2016;455:68–74. https://doi.org/10.1016/j.cca.2016.01.026.Suche in Google Scholar PubMed

20. Szöke, D, Birindelli, S, Pasqualetti, S, Dolci, A, Panteghini, M. Are blood ammonia concentrations dependent on γ-glutamyl-transferase levels in plasma? J Clin Pathol 2016;69:551–2. https://doi.org/10.1136/jclinpath-2015-203520.Suche in Google Scholar PubMed

21. CLSI. Handling, transport, processing and storage of blood specimens for routine laboratory examinations. 1st ed. CLSI guideline PRE04. Clinical and Laboratory Standards Institute; 2023.Suche in Google Scholar

22. Bélanger-Quintana, A, Arrieta Blanco, F, Barrio-Carreras, D, Bergua Martínez, A, Cañedo Villarroya, E, García-Silva, MT, et al.. Recommendations for the diagnosis and therapeutic management of hyperammonaemia in paediatric and adult patients. Nutrients 2022;14. https://doi.org/10.3390/nu14132755.Suche in Google Scholar PubMed PubMed Central

23. Favresse, J, Despas, N, Boland, L, Gruson, D, Laterre, PF, Nassogne, MC, et al.. Preanalytics of ammonia: stability, transport and temperature of centrifugation. Clin Chem Lab Med 2018;56:65–8. https://doi.org/10.1515/cclm-2017-0751.Suche in Google Scholar PubMed

Received: 2024-11-11
Accepted: 2024-12-16
Published Online: 2025-01-06
Published in Print: 2025-05-26

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorials
  3. The Friedewald formula strikes back
  4. Liquid biopsy in oncology: navigating technical hurdles and future transition for precision medicine
  5. The neglected issue of pyridoxal- 5′ phosphate
  6. Reviews
  7. Health literacy: a new challenge for laboratory medicine
  8. Clinical applications of circulating tumor cell detection: challenges and strategies
  9. Opinion Papers
  10. Pleural effusion as a sample matrix for laboratory analyses in cancer management: a perspective
  11. Interest of hair tests to discriminate a tail end of a doping regimen from a possible unpredictable source of a prohibited substance in case of challenging an anti-doping rule violation
  12. Perspectives
  13. Sigma Metrics misconceptions and limitations
  14. EN ISO 15189 revision: EFLM Committee Accreditation and ISO/CEN standards (C: A/ISO) analysis and general remarks on the changes
  15. General Clinical Chemistry and Laboratory Medicine
  16. Evaluation of current indirect methods for measuring LDL-cholesterol
  17. Verification of automated review, release and reporting of results with assessment of the risk of harm for patients: the procedure algorithm proposal for clinical laboratories
  18. Progranulin measurement with a new automated method: a step forward in the diagnostic approach to neurodegenerative disorders
  19. A comparative analysis of current С-peptide assays compared to a reference method: can we overcome inertia to standardization?
  20. Blood samples for ammonia analysis do not require transport to the laboratory on ice: a study of ammonia stability and cause of in vitro ammonia increase in samples from patients with hyperammonaemia
  21. A physio-chemical mathematical model of the effects of blood analysis delay on acid-base, metabolite and electrolyte status: evaluation in blood from critical care patients
  22. Evolution of autoimmune diagnostics over the past 10 years: lessons learned from the UK NEQAS external quality assessment EQA programs
  23. Comparison between monotest and traditional batch-based ELISA assays for therapeutic drug monitoring of infliximab and adalimumab levels and anti-drug antibodies
  24. Evaluation of pre-analytical factors impacting urine test strip and chemistry results
  25. Evaluation of AUTION EYE AI-4510 flow cell morphology analyzer for counting particles in urine
  26. Reference Values and Biological Variations
  27. Estimation of the allowable total error of the absolute CD34+ cell count by flow cytometry using data from UK NEQAS exercises 2004–2024
  28. Establishment of gender– and age–related reference intervals for serum uric acid in adults based on big data from Zhejiang Province in China
  29. Cancer Diagnostics
  30. Tumor specific protein 70 targeted tumor cell isolation technology can improve the accuracy of cytopathological examination
  31. Cardiovascular Diseases
  32. Diagnostic performance of Mindray CL1200i high sensitivity cardiac troponin I assay compared to Abbott Alinity cardiac troponin I assay for the diagnosis of type 1 and 2 acute myocardial infarction in females and males: MERITnI study
  33. Infectious Diseases
  34. Evidence-based assessment of the application of Six Sigma to infectious disease serology quality control
  35. Letters to the Editor
  36. Evaluating the accuracy of ChatGPT in classifying normal and abnormal blood cell morphology
  37. Refining within-subject biological variation estimation using routine laboratory data: practical applications of the refineR algorithm
  38. Early rule-out high-sensitivity troponin protocols require continuous analytical robustness: a caution regarding the potential for troponin assay down-calibration
  39. Biochemical evidence of vitamin B12 deficiency: a crucial issue to address supplementation in pregnant women
  40. Plasmacytoid dendritic cell proliferation and acute myeloid leukemia with minimal differentiation (AML-M0)
  41. Failing methemoglobin blood gas analyses in a sodium nitrite intoxication
Heruntergeladen am 11.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2024-1304/html
Button zum nach oben scrollen